Mariner, LLC Invitae Corp Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $9,277 - $23,658	15,463 New	15,463 $9,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.73 $9,079 - $20,655	-7,566 Reduced 38.05%	12,318 $17,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $4,153 - $8,768	-2,429 Reduced 10.89%	19,884 $37,000
Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $42,394 - $192,561	22,313 New	22,313 $55,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.